Echo Therapeutics

Hospitals

Needle-free transdermal glucose monitor for critical care patients gets positive trial results

A needle-free, transdermal glucose monitoring device for critical care patients has generated positive results in the second of two clinical trials. The study for Echo Therapeutics‘ (NASDAQ:ECTE) Symphony system was performed at Thomas Jefferson University Hospital. It enrolled 15 adult patients in critical care settings undergoing major general surgery and cardiothoracic surgery. Reference blood samples […]

By Stephanie Baum
presented by
Hospitals

Glucose monitor gives continuous reading with needle-free technology

A medical device company with a glucose monitoring system offering needle-free technology providing a constant reading of glucose levels for diabetics sees opportunities for transdermal drug-delivery uses for the product. Echo Therapeutics (NASDAQ:ECTE) is poised to begin a new clinical trial of its glucose monitoring system next month, this time for critical care patients. The […]

By Stephanie Baum
Devices & Diagnostics

Echo Therapeutics’ ECTE moves from OTC to the NASDAQ

Echo Therapeutics (OTC:ECTE) announced that its common stock, previously granted Over-the-Counter status, has graduated to the NASDAQ exchange. The stock will continue to trade under the “ECTE” symbol. “We welcome Echo Therapeutics, Inc. to the NASDAQ family of listed healthcare companies,” said Robert McCooey, Jr., senior VP of New Listings and Capital Markets, NASDAQ OMX. […]

By MassDevice Staff